questionText: To ask the Secretary of State for Health and Social Care, what recent steps he has taken mitigate the impact of shortages of (a) Ozempic, (b) Rybelsus, (c) Trulicity, (d) Victoza, (e) Saxenda, (f) Byetta and (g) Bydureon.
answerText: We are aware of a supply issue with GLP-1 RA medicines. This includes Ozempic, Rybelsus, Trulicity, Victoza, Saxenda, Byetta and Bydureon. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July 2023, issued a National Patient...
heading: Diabetes: Drugs